논문 상세보기

An electrochemical immunosensor based on a graphene/ multi‑wall carbon nanotube composite platform for the detection of cardiovascular marker C‑reactive protein KCI 등재

  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/435072
구독 기관 인증 시 무료 이용이 가능합니다. 4,000원
Carbon Letters (Carbon letters)
한국탄소학회 (Korean Carbon Society)
초록

This paper presents an electrochemical immunosensor using a graphene/multi-walled carbon nanotube (MWCNT) composite platform for detecting the cardiovascular marker C-reactive protein (CRP). The immunosensor exhibited a linear detection range of 0.20–100 ng/mL CRP with a low limit of detection reaching 0.081 ng/mL. The composite material provided a 3D porous structure that allowed efficient antibody immobilization and minimized steric hindrance. The sensor showed high specificity, with minimal response to interfering substances. Using differential pulse voltammetry, the immunosensor demonstrated exceptional precision, rapid detection, and a direct correlation between CRP concentration and sensor response current. Overall, this work highlights the potential of the graphene/MWCNT composite platform as a robust tool for early CRP detection and cardiovascular disease risk assessment. The immunosensor provides sensitive and selective CRP quantification that could enable timely clinical intervention for at-risk individuals.

목차
An electrochemical immunosensor based on a graphenemulti-wall carbon nanotube composite platform for the detection of cardiovascular marker C-reactive protein
    Abstract
    1 Introduction
    2 Experimental
        2.1 Preparation of graphenemulti-wall carbon nanotube composite platform
        2.2 Preparation of anthraquinone dicarboxylic acid labeled CRP antibody
        2.3 Preparation of electrochemical immunosensor and detection
    3 Results and discussion
    4 Conclusion
    References
저자
  • Jingjing Du(Graduate School, Jinzhou Medical University, Jinzhou 121000, Liaoning, China)
  • Yuedong Ma(Student Affairs Office, Jinzhou Medical University, Jinzhou 121000, Liaoning, China)
  • Yanyun Wang(Department of Medical Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, Liaoning, China) Corresponding author